Pfizer soars on the buzz of its parent company identifies some antiviral compounds to inhibit coronavirus

03 Mar 2020 Evaluate

Pfizer is currently trading at Rs. 4416.75, up by 157.90 points or 3.71% from its previous closing of Rs. 4258.85 on the BSE.

The scrip opened at Rs. 4274.95 and has touched a high and low of Rs. 4929.85 and Rs. 4271.15 respectively. So far 36100 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4,929.85 on 03-Mar-2020 and a 52 week low of Rs. 2797.50 on 23-Aug-2019.

Last one week high and low of the scrip stood at Rs. 4929.85 and Rs. 4054.85 respectively. The current market cap of the company is Rs. 20213.41 crore.

The promoters holding in the company stood at 63.92%, while Institutions and Non-Institutions held 16.72% and 19.36% respectively.

Pfizer’s parent company in the US has reportedly found some antiviral compounds that have the potential to inhibit coronavirus. The company is engaging with a third party to screen the compounds and it hopes that they would get the results from screening by the end of March. If any of the compounds are successful the company would start testing them by the end of the year.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4595.60 -127.70 (-2.70%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×